OSR Health (OSRHW) Current Assets (2021 - 2026)
OSR Health (OSRHW) posted Current Assets of $2.9 million for Q1 2026, up 3.77% sequentially from $2.8 million in Q4 2025, and down 15.69% YoY from $3.5 million in Q1 2025.
OSR Health (OSRHW) Current Assets (2021 - 2026) Analysis & Trends
OSR Health has reported Current Assets for 6 years, with the latest figure at $2.9 million in Q1 2026.
- Quarterly Current Assets fell 15.69% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 15.69% YoY) and the FY2025 annual result came in at $2.8 million, up 21.08% from the prior year.
- Current Assets advanced to $2.9 million in Q1 2026 per OSRHW's latest filing, from $2.8 million in the prior quarter.
- Over five years, Current Assets peaked at $3.5 million in Q1 2025 and troughed at $22627.0 in Q4 2023.
- A 5-year average of $1.3 million and a median of $298351.5 in 2023 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 10181.92% in 2024, down 84.14% in 2024.
- Over 5 years, Current Assets stood at $124501.0 in 2022, then slumped by 81.83% to $22627.0 in 2023, then surged by 10181.92% to $2.3 million in 2024, then grew by 21.08% to $2.8 million in 2025, then advanced by 3.77% to $2.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $2.9 million, $2.8 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.76 Bn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 1.63 Bn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.92 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 39,608.00 |
| Jun 30, 2024 | 166,828.00 |
| Mar 31, 2024 | 68,180.00 |
| Dec 31, 2023 | 22,627.00 |
| Sep 30, 2023 | 82,414.00 |
| Jun 30, 2023 | 58,976.00 |
| Mar 31, 2023 | 429,875.00 |
| Dec 31, 2022 | 124,501.00 |
| Dec 31, 2021 | 4,757.00 |